Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

7.83
Delayed Data
As of Jul 29
 -0.29 / -3.57%
Today’s Change
6.72
Today|||52-Week Range
9.24
+4.40%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close8.12
Today’s open8.14
Day’s range-- - --
Volume35,561
Average volume (3 months)29,543
Market cap$77.6M
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-26.14%
Earnings growth (this year)+4.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+16,502.46%
P/E ratioNM
Price/Sales41.26
Price/Book9.22

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...+0.02+1.36%
STDYSteadymed Ltd-0.03-0.54%
MSTXMast Therapeutics In...-0.01-1.26%
OGENOragenics Inc+0.29+16.67%
Data as of 07/29/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$1.7M
Annual profit (last year)-$10.1M
Net profit margin-609.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts